Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (71-80 of 364) with videos related to

Pageof 37
Sort By:
Journal of Virological Methods|June 18, 2005
Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studiesYamima Talukder, Robin Gopal, Nick Andrews, et al.
BMC Medicine|February 9, 2018
Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite controlDominic Thorrington, Nick Andrews, Julia Stowe, et al.
Emerging Infectious Diseases|April 8, 2011
Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006Chee Fu Yung, Nick Andrews, Antoaneta Bukasa, et al.
Vaccine|September 30, 2018
Inequalities in childhood vaccination timing and completion in LondonKaren S Tiley, Joanne M White, Nick Andrews, et al.
Plos One|April 23, 2020
Disease misclassification in electronic healthcare database studies: Deriving validity indices-A contribution from the ADVANCE projectKaatje Bollaerts, Alexandros Rekkas, Tom De Smedt, et al.
Human Vaccines|September 6, 2007
Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccinationJill Morris, Natasha S Crowcroft, Anthony R Fooks, et al.
Lancet (London, England)|November 1, 2011
Guillain-Barré syndrome and H1N1 influenza vaccine in UK childrenChristopher Verity, Lesley Stellitano, Anne Marie Winstone, et al.
Frontiers in Pharmacology|May 17, 2018
Up-Down Reader: An Open Source Program for Efficiently Processing 50% von Frey ThresholdsRafael Gonzalez-Cano, Bruno Boivin, Daniel Bullock, et al.
The Journal of Infection|May 8, 2024
Effectiveness of autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control studyFreja C M Kirsebom, Julia Stowe, Jamie Lopez Bernal, et al.
The Lancet. Infectious Diseases|July 15, 2023
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control studyFreja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, et al.
Pageof 37

Showing results (71-80 of 364) with videos related to

Sort By:
Pageof 37
Journal of Virological Methods|June 18, 2005
Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studiesYamima Talukder, Robin Gopal, Nick Andrews, et al.
BMC Medicine|February 9, 2018
Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite controlDominic Thorrington, Nick Andrews, Julia Stowe, et al.
Emerging Infectious Diseases|April 8, 2011
Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006Chee Fu Yung, Nick Andrews, Antoaneta Bukasa, et al.
Vaccine|September 30, 2018
Inequalities in childhood vaccination timing and completion in LondonKaren S Tiley, Joanne M White, Nick Andrews, et al.
Plos One|April 23, 2020
Disease misclassification in electronic healthcare database studies: Deriving validity indices-A contribution from the ADVANCE projectKaatje Bollaerts, Alexandros Rekkas, Tom De Smedt, et al.
Human Vaccines|September 6, 2007
Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccinationJill Morris, Natasha S Crowcroft, Anthony R Fooks, et al.
Lancet (London, England)|November 1, 2011
Guillain-Barré syndrome and H1N1 influenza vaccine in UK childrenChristopher Verity, Lesley Stellitano, Anne Marie Winstone, et al.
Frontiers in Pharmacology|May 17, 2018
Up-Down Reader: An Open Source Program for Efficiently Processing 50% von Frey ThresholdsRafael Gonzalez-Cano, Bruno Boivin, Daniel Bullock, et al.
The Journal of Infection|May 8, 2024
Effectiveness of autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control studyFreja C M Kirsebom, Julia Stowe, Jamie Lopez Bernal, et al.
The Lancet. Infectious Diseases|July 15, 2023
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control studyFreja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, et al.
Pageof 37